SCHEMBL16257591

SCHEMBL16257591

CCOC(=O)c1ncnc(Nc2ccc3cc(OC)ccc3c2)c1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.50
ERBB3 P21860 1/20 0.50
KDM4E B2RXH2 5/20 0.47
MAPT P10636 5/20 0.47
TP53 P04637 3/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
LMNA P02545 3/20 0.46
NPSR1 Q6W5P4 1/20 0.46
DHODH Q02127 1/20 0.45
ALDH1A1 P00352 3/20 0.45
HPGD P15428 3/20 0.45
SHMT2 P34897 2/20 0.45
FGFR1 P11362 1/20 0.45
TARBP2 Q15633 1/20 0.44
PDCD4 Q53EL6 1/20 0.44
CSNK2A2 P19784 1/20 0.43
CSNK2B P67870 1/20 0.43
CSNK2A1 P68400 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
MAOB P27338 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16257512 0.98 EGFR (0.48) EGFRERBB3KDM4EMAPTTP53
SCHEMBL16257511 0.89 DHODH (0.55) EGFRERBB3KDM4EMAPTSMN1; SMN2
SCHEMBL16257608 0.87 HPGD (0.47) EGFRKDM4EMAPTTP53SMN1; SMN2
SCHEMBL16257609 0.86 CSF1R (0.47) EGFRERBB3KDM4EMAPTNPSR1
SCHEMBL16257513 0.84 CSF1R (0.45) EGFRERBB3KDM4EMAPTNPSR1
SCHEMBL16257575 0.80 MAPT (0.48) EGFRKDM4EMAPTTP53SMN1; SMN2
SCHEMBL12180017 0.77 CCR2 (0.49) ALDH1A1HPGDMEN1KMT2APOLB
SCHEMBL12180012 0.76 CCR2 (0.48) ALDH1A1HPGDPOLBNPC1RAB9A
SCHEMBL12179967 0.75 DHODH (0.52) TP53LMNADHODH
SCHEMBL14318457 0.75 TP53 (0.65) EGFRMAPTTP53SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8946218-B2 CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-02-03 US disclosed
EP-2569295-B1 NEW CCR2 RECEPTOR ANTAGONISTS, METHOD FOR PRODUCING THE SAME, AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM INT (DE) 2014-11-19 EP disclosed